Pharmaceutical Preparations · DE · CIK 1875558
Nuvectis Pharma develops innovative precision medicines for oncology, focusing on unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Nov 5, 2025: 4 insiders bought $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2025 | Sanchez JuanDirector | Buy | 13,000 | $5.79 | $75K |
| Nov 5, 2025 | Kaplan Matthew L.Director | Buy | 11,000 | $5.84 | $64K |
| Nov 5, 2025 | Bentsur RonChairman & CEO | Buy | 5,000 | $5.72 | $29K |
| Oct 27, 2025 | Mosseri Marlio CharlesTenPercentOwner | Buy | 72,836 | $6.28 | $457K |
| Oct 24, 2025 | Mosseri Marlio CharlesTenPercentOwner | Buy | 35,034 | $6.15 | $215K |
| Oct 23, 2025 | Mosseri Marlio CharlesTenPercentOwner | Buy | 46,900 | $6.06 | $284K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.